1. Home
  2. TIL vs MHI Comparison

TIL vs MHI Comparison

Compare TIL & MHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • MHI
  • Stock Information
  • Founded
  • TIL 2018
  • MHI 2003
  • Country
  • TIL United States
  • MHI United States
  • Employees
  • TIL N/A
  • MHI N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • MHI Investment Managers
  • Sector
  • TIL Health Care
  • MHI Finance
  • Exchange
  • TIL Nasdaq
  • MHI Nasdaq
  • Market Cap
  • TIL 171.7M
  • MHI 198.1M
  • IPO Year
  • TIL 2021
  • MHI N/A
  • Fundamental
  • Price
  • TIL $13.23
  • MHI $9.33
  • Analyst Decision
  • TIL Buy
  • MHI
  • Analyst Count
  • TIL 5
  • MHI 0
  • Target Price
  • TIL $114.00
  • MHI N/A
  • AVG Volume (30 Days)
  • TIL 180.4K
  • MHI 98.8K
  • Earning Date
  • TIL 05-20-2025
  • MHI 01-01-0001
  • Dividend Yield
  • TIL N/A
  • MHI 4.09%
  • EPS Growth
  • TIL N/A
  • MHI N/A
  • EPS
  • TIL N/A
  • MHI 0.04
  • Revenue
  • TIL N/A
  • MHI N/A
  • Revenue This Year
  • TIL N/A
  • MHI N/A
  • Revenue Next Year
  • TIL N/A
  • MHI N/A
  • P/E Ratio
  • TIL N/A
  • MHI $219.25
  • Revenue Growth
  • TIL N/A
  • MHI N/A
  • 52 Week Low
  • TIL $9.62
  • MHI $6.93
  • 52 Week High
  • TIL $92.00
  • MHI $9.05
  • Technical
  • Relative Strength Index (RSI)
  • TIL 44.22
  • MHI 64.73
  • Support Level
  • TIL $11.97
  • MHI $9.05
  • Resistance Level
  • TIL $14.67
  • MHI $9.17
  • Average True Range (ATR)
  • TIL 2.05
  • MHI 0.09
  • MACD
  • TIL -0.04
  • MHI 0.05
  • Stochastic Oscillator
  • TIL 17.87
  • MHI 96.03

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About MHI Pioneer Municipal High Income Fund Inc.

Pioneer Municipal High Income Trust is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income exempt from regular federal income tax and capital appreciation. The trust invests in various sectors such as health, education, tobacco, facilities, transportation, utilities, airport, water, and other sectors.

Share on Social Networks: